New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2017.
作者信息
van Krieken J Han
机构信息
Department of Pathology, Radboud University Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
出版信息
J Hematop. 2017 Jul 22;10(1):25-33. doi: 10.1007/s12308-017-0295-x. eCollection 2017 Mar.
Abstract
摘要
相似文献
1
New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2017.恶性淋巴瘤病理学的新进展：2017年1月至4月发表文献综述
J Hematop. 2017 Jul 22;10(1):25-33. doi: 10.1007/s12308-017-0295-x. eCollection 2017 Mar.
2
New developments in the pathology of malignant lymphoma. A review of the literature published from January-April 2016.恶性淋巴瘤病理学的新进展。对2016年1月至4月发表的文献综述。
J Hematop. 2016 Jun 13;9(2):73-83. doi: 10.1007/s12308-016-0277-4. eCollection 2016 Jun.
3
New developments in the pathology of malignant lymphoma: a review of literature published from January 2015 to April 2015.恶性淋巴瘤病理学的新进展：2015年1月至2015年4月发表文献综述
J Hematop. 2015 Jun 17;8(2):71-79. doi: 10.1007/s12308-015-0249-0. eCollection 2015 Jun.
4
New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.恶性淋巴瘤病理学的新进展：2008年1月至4月发表文献综述
J Hematop. 2008 Jul;1(1):37-45. doi: 10.1007/s12308-008-0010-z.
5
New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.恶性淋巴瘤病理学的新进展：2009年1月至8月发表文献综述
J Hematop. 2009 Sep 26;2(3):171-83. doi: 10.1007/s12308-009-0046-8.
6
New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.恶性淋巴瘤病理学的新进展：对2009年10月至2010年1月发表的文献综述
J Hematop. 2010 Jun;3(1):47-58. doi: 10.1007/s12308-010-0060-x. Epub 2010 Jun 2.
7
New developments in the pathology of malignant lymphoma. A review of the literature published from September-August 2017.恶性淋巴瘤病理学的新进展。对2017年9月至8月发表的文献综述。
J Hematop. 2017 Nov 29;10(3-4):117-127. doi: 10.1007/s12308-017-0310-2. eCollection 2017 Dec.
8
New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015-December 2015.恶性淋巴瘤病理学的新进展。对2015年9月至2015年12月发表的文献综述。
J Hematop. 2016 Feb 22;9(1):19-27. doi: 10.1007/s12308-016-0269-4. eCollection 2016 Mar.
9
New developments in the pathology of malignant lymphoma: a review of the literature published from June-August 2016.恶性淋巴瘤病理学的新进展：2016年6月至8月发表文献综述
J Hematop. 2016 Sep 30;9(3):129-134. doi: 10.1007/s12308-016-0284-5. eCollection 2016 Sep.
10
New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017.恶性淋巴瘤病理学的新进展：2017年5月至8月发表文献综述
J Hematop. 2017 Sep 30;10(2):65-73. doi: 10.1007/s12308-017-0303-1. eCollection 2017 Jun.
引用本文的文献
1
New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017.恶性淋巴瘤病理学的新进展：2017年5月至8月发表文献综述
J Hematop. 2017 Sep 30;10(2):65-73. doi: 10.1007/s12308-017-0303-1. eCollection 2017 Jun.
本文引用的文献
1
Chronic amastigote-negative cutaneous leishmaniasis: A clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentations.慢性无鞭毛体阴性皮肤利什曼病：27例临床、组织病理学及分子学研究，重点关注非典型和假淋巴瘤表现
J Cutan Pathol. 2017 Jun;44(6):530-537. doi: 10.1111/cup.12927. Epub 2017 Apr 10.
2
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.适用于福尔马林固定石蜡包埋活检组织的套细胞淋巴瘤增殖特征新分子检测法。
J Clin Oncol. 2017 May 20;35(15):1668-1677. doi: 10.1200/JCO.2016.70.7901. Epub 2017 Mar 14.
3
MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.MYC蛋白阳性弥漫性大B细胞淋巴瘤具有活化的B细胞受体信号通路特征。
Am J Surg Pathol. 2017 Apr;41(4):541-549. doi: 10.1097/PAS.0000000000000799.
4
LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.LMO2阴性表达可预测侵袭性B细胞淋巴瘤中MYC易位的存在。
Am J Surg Pathol. 2017 Jul;41(7):877-886. doi: 10.1097/PAS.0000000000000839.
5
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.眼附属器淋巴增殖性疾病的局部疾病控制：黏膜相关淋巴组织淋巴瘤（MALT）与非MALT组织学类型的比较结果
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):305-311.e2. doi: 10.1016/j.clml.2017.02.002. Epub 2017 Feb 16.
6
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.结外 NK/T 细胞淋巴瘤，鼻型中的新型 JAK3 激活突变。
Am J Pathol. 2017 May;187(5):980-986. doi: 10.1016/j.ajpath.2017.01.004. Epub 2017 Mar 9.
7
Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.IgM单克隆丙种球蛋白病相关疾病患者中MYD88 L265P和WHIM样CXCR4突变的检测
Ann Hematol. 2017 Jun;96(6):971-976. doi: 10.1007/s00277-017-2968-z. Epub 2017 Mar 9.
8
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.葡萄糖转运蛋白1作为经典型霍奇金淋巴瘤的预后因素：与程序性死亡受体配体1和程序性死亡受体配体2表达的相关性
J Pathol Transl Med. 2017 Mar;51(2):152-158. doi: 10.4132/jptm.2016.11.03. Epub 2017 Feb 21.
9
Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence.伴有MYC和BCL2高表达的弥漫性大B细胞淋巴瘤通过定量免疫荧光显示出活跃的B细胞受体信号传导的证据。
PLoS One. 2017 Feb 17;12(2):e0172364. doi: 10.1371/journal.pone.0172364. eCollection 2017.
10
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.根据非霍奇金淋巴瘤柏林-法兰克福-明斯特方案治疗的儿童侵袭性B细胞淋巴瘤中ID3-TCF3-CCND3通路突变的相关性
Haematologica. 2017 Jun;102(6):1091-1098. doi: 10.3324/haematol.2016.156885. Epub 2017 Feb 16.
Zotero 插件